1. ADA. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes - 2022. Diabetes Care. 2022; 45(Supplement-1): S17-S38.
2. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes research and clinical practice. 2019; 157: 107843.
3. Larejani B, Zahedi F. Epidemiology of Diabetes Mellitus in IRAN. Iranian Journal of Diabetes and Lipid Disorders. 2001; 1(1): 1-8.
4. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378(9785): 31-40.
5. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010; 87(1): 4-14.
6. Van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan G-O, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018; 41(4): 782-8.
7. Buchleitner AM, Martínez-Alonso M, Hernández M, Solà I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev. 2012(9): Cd007315.
8. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Hegarty C, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008; 36(8): 2249-55.
9. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3): 978-82.
10. Kosiborod M. Blood glucose and its prognostic implications in patients hospitalised with acute myocardial infarction. Diabetes and Vascular Disease Research. 2008; 5(4): 269-75.
11. King JT, Jr., Goulet JL, Perkal MF, Rosenthal RA. Glycemic control and infections in patients with diabetes undergoing noncardiac surgery. Ann Surg. 2011; 253(1): 158-65.
12. Frisch A, Chandra P, Smiley D, Peng L, Rizzo M, Gatcliffe C, et al. Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac Surgery. Diabetes Care. 2010; 33(8): 1783-8.
13. Abdelmalak BB, Knittel J, Abdelmalak JB, Dalton JE, Christiansen E, Foss J, et al. Preoperative blood glucose concentrations and postoperative outcomes after elective non-cardiac surgery: an observational study. Br J Anaesth. 2014; 112(1): 79-88.
14. Blondet JJ, Beilman GJ. Glycemic control and prevention of perioperative infection. Curr Opin Crit Care. 2007; 13(4): 421-7.
15. Nadia A Khan M, MScWilliam A Ghali, MD, MPHEnrico Cagliero, MD. Perioperative management of blood glucose in adults with diabetes mellitus. Feb 12, 2021. In: UpToDate [Internet]. UpToDate, Waltham, MA.
16. Sebranek J, Lugli AK, Coursin D. Glycaemic control in the perioperative period. British journal of anaesthesia. 2013; 111(suppl-1): i18-i34.
17. Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. AACE/ADA Consensus Statement. Endocrine Practice. 2009; 15(4): 353-69.
18. Committee ADAPP. 16. Diabetes Care in the Hospital: Standards of Medical Care in
Diabetes-2022. Diabetes Care. 2021; 45
(Supplement-1): S244-S53.
19. Gustafsson UO, Thorell A, Soop M, Ljungqvist O, Nygren J. Haemoglobin A1c as a predictor of postoperative hyperglycaemia and complications after major colorectal surgery. Br J Surg. 2009; 96(11): 1358-64.
20. O'sullivan C, Hynes N, Mahendran B, Andrews E, Avalos G, Tawfik S, et al. Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? European journal of vascular and endovascular surgery. 2006; 32(2):
188-97.
21. Intensive versus Conventional Glucose Control in Critically Ill Patients. New England Journal of Medicine. 2009; 360(13): 1283-97.
22. Dhatariya K, Levy N, Kilvert A, Watson B, Cousins D, Flanagan D, et al. NHS Diabetes guideline for the perioperative management of the adult patient with diabetes. Diabet Med. 2012; 29(4): 420-33.
23. Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(1): 16-38.
24. Zinman B, Wanner C, Lachin JM, Fitchett D, Bluhmki E, Hantel S, et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. N Engl J Med. 2015; 373(22):
2117-28.
25. Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. New England Journal of Medicine. 2016; 375(4):
323-34.
26. Handelsman Y, Henry RR, Bloomgarden ZT, Dagogo-Jack S, DeFronzo RA, Einhorn D, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the Association of SGLT-2 inhibitors and Diabetic Ketoacidosis. Endocr Pract. 2016; 22(6): 753-62.
27. Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010(1): Cd002967.
28. Duggan EW, Carlson K, Umpierrez GE. Perioperative Hyperglycemia Management: An Update. Anesthesiology. 2017; 126(3): 547-60.
29. Pasquel FJ, Lansang MC, Dhatariya K, Umpierrez GE. Management of diabetes and hyperglycaemia in the hospital. The Lancet Diabetes & Endocrinology. 2021; 9(3): 174-88.
30. Joshi GP, Chung F, Vann MA, Ahmad S,
Gan TJ, Goulson DT, et al. Society for
Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in
Diabetic Patients Undergoing Ambulatory
Surgery. Anesthesia & Analgesia. 2010; 111(6): 1378-87.
31. Demma LJ, Carlson KT, Duggan EW, Morrow JG, 3rd, Umpierrez G. Effect of basal insulin dosage on blood glucose concentration in ambulatory surgery patients with type 2 diabetes. J Clin Anesth. 2017; 36: 184-8.
32. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am. 1997; 26(3): 631-45.
